Login to Your Account

FDA Ethics Panel Tackles Pediatric MCM

By Catherine Shaffer
Staff Writer

Monday, September 9, 2013
The Pediatric Ethics Subcommittee of the Pediatric Advisory Committee convened Monday morning for a two-day meeting to hammer out the difficult ethical issues related to development of pediatric medical countermeasures (MCM).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription